基本信息
出版地:United Kingdom
期刊简称:SIGNAL TRANSDUCT TAR
通讯地址:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
创刊年份:2016
发行周期:1 issue/year
涉及方向:Biochemistry, Genetics and Molecular Biology - Genetics
ESSN:2059-3635
英文期刊简介
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
中文期刊简介
《Signal Transduction And Targeted Therapy》是一本由SPRINGERNATURE出版商出版的专业医学期刊，该刊创刊于2016年，刊期1 issue/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 1区，小类学科：生化与分子生物学 1区；细胞生物学 1区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖生化与分子生物学等领域，旨在及时、准确、全面地报道国内外生化与分子生物学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为38.104，平均审稿速度5 Weeks。
